Regent Peak Wealth Advisors LLC Gilead Sciences, Inc. Transaction History

Regent Peak Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $165,895 - $238,169	2,662 New	2,662 $228,000
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $60,540 - $69,076	-1,009 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $57,159 - $65,130	1,009 New	1,009 $59,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $343,542 - $398,916	-4,749 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $297,429 - $380,964	4,749 New	4,749 $355,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.